Evidence map›Paper›PMID 38495181›Full record

ArticleHeliyon2024

Holistic exploration of

Hossein Safarpour, Javad Ranjbaran, Nafiseh Erfanian, Samira Nomiri, Afshin Derakhshani, Casimiro Gerarduzzi, Adib Miraki Feriz, Edris HosseiniGol, Samira Saghafi, Nicola Silvestris

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Hossein SafarpourCellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran.
Javad RanjbaranDepartment of Clinical Biochemistry, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran.
Nafiseh ErfanianStudent Research Committee, Birjand University of Medical Sciences, Birjand, Iran.
Samira NomiriDepartment of Clinical Biochemistry, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran.
Afshin DerakhshaniLaboratory of Experimental Pharmacology, IRCCS Istituto Tumori Giovanni Paolo II, 70124, Bari, Italy.
Casimiro GerarduzziCentre de Recherche de l'Hôpital Maisonneuve-Rosemont, Montréal, Québec, Canada.
Adib Miraki FerizStudent Research Committee, Birjand University of Medical Sciences, Birjand, Iran.
Edris HosseiniGolDepartment of Computer Engineering, University of Birjand, Birjand, Iran.
Samira SaghafiCellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran.
Nicola SilvestrisMedical Oncology Unit, Department of Human Pathology "G. Barresi", University of Messina, Messina, Italy.
Birjand University of Medical Sciences · IRHôpital Maisonneuve-Rosemont · CAIstituto Tumori Bari · ITUniversity of Birjand · IRUniversity of Messina · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer (CRC) ranks among the most widespread malignancies globally, with early detection significantly influencing prognosis. Employing a systems biology approach, we aimed to unravel the intricate mRNA-miRNA network linked to CRC pathogenesis, potentially yielding diagnostic biomarkers. Through an integrative analysis of microarray, Bulk RNA-seq, and single-cell RNA-seq data, we explored CRC-related transcriptomes comprehensively. Differential gene expression analysis uncovered crucial genes, while Weighted Gene Co-expression Network Analysis (WGCNA) identified key modules closely linked to CRC. Remarkably, CRC manifested its strongest correlation with the turquoise module, signifying its pivotal role. From the cohort of genes showing high Gene Significance (GS) and Module Membership (MM), and Differential Expression Genes (DEGs), we highlighted the downregulated Chromogranin A (

Indexed as

BiomarkerCHGAColorectal cancerHsa-miR-137Single-cell RNA sequencingWGCNA

Identifiers

PMID38495181
PMCPMC10943347
OpenAlexW4392343598

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.